Literature DB >> 10980876

Anticoagulant therapy in special circumstances.

T G DeLoughery1.   

Abstract

Situations often occur in anticoagulated patients that require adjustment of anticoagulation therapy. These situations often place the patient at risk of bleeding, and often there is little clinical data to guide the clinician. This paper reviews several of these situations and offers guidance for the management of patients. The problems reviewed concern the patient on anticoagulants who is or desires to get pregnant, peri-operative management of anticoagulated patients, anticoagulated patients with intracranial bleeding or endocarditis, and the "warfarin refractory" patient.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980876     DOI: 10.1007/s11886-000-0029-y

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  47 in total

Review 1.  Heparin-induced osteoporosis.

Authors:  C Nelson-Piercy
Journal:  Scand J Rheumatol Suppl       Date:  1998

Review 2.  Current concepts of anticoagulant therapy in pregnancy.

Authors:  L A Barbour
Journal:  Obstet Gynecol Clin North Am       Date:  1997-09       Impact factor: 2.844

3.  Trousseau's syndrome.

Authors:  N Callander; S I Rapaport
Journal:  West J Med       Date:  1993-04

Review 4.  Safety of low-molecular-weight heparin in pregnancy: a systematic review.

Authors:  B J Sanson; A W Lensing; M H Prins; J S Ginsberg; Z S Barkagan; E Lavenne-Pardonge; B Brenner; M Dulitzky; J D Nielsen; Z Boda; S Turi; M R Mac Gillavry; K Hamulyák; I M Theunissen; B J Hunt; H R Büller
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

5.  Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk.

Authors:  C Nelson-Piercy; E A Letsky; M de Swiet
Journal:  Am J Obstet Gynecol       Date:  1997-05       Impact factor: 8.661

6.  The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events.

Authors:  L I Kupferwasser; G Hafner; S Mohr-Kahaly; R Erbel; J Meyer; H Darius
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

7.  Infective endocarditis due to Staphylococcus aureus: deleterious effect of anticoagulant therapy.

Authors:  P Tornos; B Almirante; S Mirabet; G Permanyer; A Pahissa; J Soler-Soler
Journal:  Arch Intern Med       Date:  1999-03-08

Review 8.  Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.

Authors:  P D Stein; J S Alpert; J E Dalen; D Horstkotte; A G Turpie
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

9.  Prosthetic valve endocarditis 1976-1987. Antibiotics, anticoagulation, and stroke.

Authors:  J Davenport; R G Hart
Journal:  Stroke       Date:  1990-07       Impact factor: 7.914

10.  Continuous subcutaneous heparin infusion for treatment of Trousseau's syndrome.

Authors:  C P Alderman; A F McClure; H P Jersmann; S D Scott
Journal:  Ann Pharmacother       Date:  1995 Jul-Aug       Impact factor: 3.154

View more
  1 in total

Review 1.  Antithrombotic therapy for prosthetic valves: routine treatment and special considerations.

Authors:  A M Al-Ahmad; D Hartnett-Daudelin; D N Salem
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.